Identical de novo Mutation in the Type 1 Ryanodine Receptor Gene Associated with Fatal, Stress-induced Malignant Hyperthermia in Two Unrelated Families
Open Access
- 1 November 2011
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesiology
- Vol. 115 (5), 938-945
- https://doi.org/10.1097/aln.0b013e3182320068
Abstract
Background Mutations in the type 1 ryanodine receptor gene (RYR1) result in malignant hyperthermia, a pharmacogenetic disorder typically triggered by administration of anesthetics. However, cases of sudden death during exertion, heat challenge, and febrile illness in the absence of triggering drugs have been reported. The underlying causes of such drug-free fatal "awake" episodes are unknown. Methods De novo R3983C variant in RYR1 was identified in two unrelated children who experienced fatal, nonanesthetic awake episodes associated with febrile illness and heat stress. One of the children also had a second novel, maternally inherited D4505H variant located on a separate haplotype. Effects of all possible heterotypic expression conditions on RYR1 sensitivity to caffeine-induced Ca release were determined in expressing RYR1-null myotubes. Results Compared with wild-type RYR1 alone (EC50 = 2.85 ± 0.49 mM), average (± SEM) caffeine sensitivity of Ca release was modestly increased after coexpression with either R3983C (EC50 = 2.00 ± 0.39 mM) or D4505H (EC50 = 1.64 ± 0.24 mM). Remarkably, coexpression of wild-type RYR1 with the double mutant in cis (R3983C-D4505H) produced a significantly stronger sensitization of caffeine-induced Ca release (EC50 = 0.64 ± 0.17 mM) compared with that observed after coexpression of the two variants on separate subunits (EC50 = 1.53 ± 0.18 mM). Conclusions The R3983C mutation potentiates D4505H-mediated sensitization of caffeine-induced RYR1 Ca release when the mutations are in cis (on the same subunit) but not when present on separate subunits. Nevertheless, coexpression of the two variants on separate subunits still resulted in a ∼2-fold increase in caffeine sensitivity, consistent with the observed awake episodes and heat sensitivity.Keywords
This publication has 28 references indexed in Scilit:
- Administration of Ondansetron Is Associated With Lethal OutcomePEDIATRICS, 2010
- KING-DENBOROUGH SYNDROME CAUSED BY A NOVEL MUTATION IN THE RYANODINE RECEPTOR GENENeurology, 2008
- Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathiesBrain, 2007
- Mutations inRYR1in malignant hyperthermia and central core diseaseHuman Mutation, 2006
- Malignant Hyperthermia in North AmericaAnesthesiology, 2004
- Role of the Sequence Surrounding Predicted Transmembrane Helix M4 in Membrane Association and Function of the Ca2+ Release Channel of Skeletal Muscle Sarcoplasmic Reticulum (Ryanodine Receptor Isoform 1)Online Journal of Public Health Informatics, 2004
- Three-dimensional Reconstruction of the Recombinant Type 2 Ryanodine Receptor and Localization of Its Divergent Region 1Online Journal of Public Health Informatics, 2002
- Evidence for Susceptibility to Malignant Hyperthermia in Patients with Exercise-induced RhabdomyolysisAnesthesiology, 2001
- Dominantly inherited malignant hyperthermia (MH) in the King-Denborough SyndromeMuscle & Nerve, 1992
- Standardization of the Caffeine Halothane Muscle Contracture TestAnesthesia & Analgesia, 1989